NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ready Capital Corporation ("Ready Capital" or "the Company") (NYSE:RC). Investors who purchased Ready Capital securities prior to November 7, 2024, and continue to hold to the present, are encouraged […]
Pomerantz LLP is investigating claims on behalf of investors of Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ: COIN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Coinbase and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged
Pomerantz LLP is investigating claims on behalf of investors ofFulgent Genetics, Inc. (“Fulgent” or the “Company”)(NASDAQ: FLGT).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Fulgentand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining
Pomerantz LLP is investigating claims on behalf of investors ofUroGen Pharma Ltd.(“UroGen” or the “Company”)(NASDAQ: URGN).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether UroGenand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the
PomerantzLLP is investigating claims on behalf of investors ofTravere Therapeutics, Inc.(“Travere” or the “Company”)(NASDAQ: TVTX).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Travereand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class
Pomerantz LLP is investigating claims on behalf of investors of Meta Platforms, Inc. (“Meta” or the “Company”) (NASDAQ: META).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Meta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. (“Luminar” or the “Company”) (NASDAQ: LAZR).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Luminar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP announces that a class action lawsuit has been filed against Bakkt Holdings, Inc. (“Bakkt” or the “Company”)(NYSE: BKKT). Such investors are advised to contact DaniellePeyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Biohaven and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for